KAT2A and systemic lupus erythematosus: KAT2A has been reported to promote carcinogenesis in colorectal cancer by interacting with RNA-binding protein PTBP1 [26] and to modulate cGAS through increasing expression and post-translational modification in systemic lupus erythematosus [27].